Breakthrough in designing a better Salmonella vaccine

UC Davis researchers announce in the Proceedings of the National Academy of Sciences a breakthrough in understanding which cells afford optimal protection against Salmonella infection–a critical step in developing a more effective and safe vaccine against a bacterium that annually kills an estimated one million people worldwide. Professor Stephen McSorley, interim director of the Center for Comparative Medicine, led a collaborative group of scientists from the University of Melbourne, Australia, the University of Connecticut and UC Davis. They evaluated the difference between circulating and non-circulating memory T cells in providing immunity to Salmonella infection in mice models. “What everyone has been focused on in immunology, not just in addressing Salmonella, but all infectious diseases for the past 50 years or so, has been antibody and T cell responses,” McSorley said. “What hasn’t been realized until very recently is there are actually two different categories of T cells–those that circulate through tissues in the...